Chen Sara C, Carton Ann-Katherine, Albert Michael, Conant Emily F, Schnall Mitchell D, Maidment Andrew D A
Department of Radiology, Hospital of the University of Pennsylvania, 1 Silverstein, 3400 Spruce Street, Philadelphia, PA 19104, USA.
Acad Radiol. 2007 Feb;14(2):229-38. doi: 10.1016/j.acra.2006.10.022.
Contrast-enhanced digital mammography and digital breast tomosynthesis are two imaging techniques that attempt to increase malignant breast lesion conspicuity. The combination of these into a single technique, contrast-enhanced digital breast tomosynthesis (CE-DBT), could potentially integrate the strengths of both. The objectives of this study were to assess the clinical feasibility of CE-DBT as an adjunct to digital mammography, and to correlate lesion enhancement characteristics and morphology obtained with CE-DBT to digital mammography, ultrasound, and magnetic resonance (MR).
CE-DBT (GE Senographe 2000D; Milwaukee, WI) was performed as a pilot study in an ongoing National Cancer Institute-funded grant (P01-CA85484) studying multimodality breast imaging. Thirteen patients with ACR BI-RADS category 4 or 5 breast lesions underwent imaging with digital mammography, ultrasound, MR, and CE-DBT. CE-DBT was performed at 49 kVp with a rhodium target and a 0.27-mm copper (Alfa Aesar, Ward Hill, MA) filter. Preinjection and postinjection DBT image sets were acquired in the medial lateral oblique projection with slight compression. Each image set consists of nine images acquired over a 50-degree arc and was obtained with a mean glandular x-ray dose comparable to two conventional mammographic views. Between the precontrast and postcontrast DBT image sets, a single bolus of iodinated contrast agent (1 ml/kg at 2 ml/s, Omnipaque-300; Amersham Health Inc., Princeton, NJ) was administered. Images were reconstructed using filtered-backprojection in 1-mm increments and transmitted to a clinical PACS workstation.
Initial experience suggests that CE-DBT provides morphologic and vascular characteristics of breast lesions qualitatively concordant with that of digital mammography and MR.
As an adjunct to digital mammography, CE-DBT may be a potential alternative tool for breast lesion morphologic and vascular characterization.
对比增强数字乳腺摄影和数字乳腺断层合成是两种旨在提高乳腺恶性病变可见性的成像技术。将这两种技术结合成一种单一技术,即对比增强数字乳腺断层合成(CE-DBT),可能会整合两者的优势。本研究的目的是评估CE-DBT作为数字乳腺摄影辅助手段的临床可行性,并将CE-DBT获得的病变增强特征和形态与数字乳腺摄影、超声和磁共振(MR)进行关联。
CE-DBT(GE Senographe 2000D;威斯康星州密尔沃基)作为一项正在进行的由美国国立癌症研究所资助的研究多模态乳腺成像的拨款(P01-CA85484)中的一项试点研究进行。13例ACR BI-RADS 4类或5类乳腺病变患者接受了数字乳腺摄影、超声、MR和CE-DBT成像。CE-DBT在49 kVp下进行,使用铑靶和0.27毫米铜(Alfa Aesar,马萨诸塞州沃德希尔)滤过器。在内外斜位投照下,轻微压迫获取注射前和注射后的DBT图像集。每个图像集由在50度弧上获取的9幅图像组成,获得的平均腺体X线剂量与两张传统乳腺摄影视图相当。在对比前和对比后的DBT图像集之间,静脉注射一剂碘化造影剂(1 ml/kg,注射速度为2 ml/s,欧乃派克-300;美国安进公司,新泽西州普林斯顿)。图像以1毫米的增量通过滤波反投影重建,并传输到临床PACS工作站。
初步经验表明,CE-DBT提供的乳腺病变形态和血管特征与数字乳腺摄影和MR在定性上一致。
作为数字乳腺摄影的辅助手段,CE-DBT可能是一种用于乳腺病变形态和血管特征描述的潜在替代工具。